{"cik":2029039,"taxonomy":"us-gaap","tag":"Assets","label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","entityName":"NASUS PHARMA LTD.","units":{"USD":[{"end":"2024-12-31","val":717000,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29"},{"end":"2024-12-31","val":717000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2024Q4I"},{"end":"2025-06-30","val":639000,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29","frame":"CY2025Q2I"},{"end":"2025-12-31","val":5004000,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2025Q4I"}]}}